The new label for prefilled syringes, in conjunction with innovations from SCHOTT Pharma, enables integrated tamper-evidence ...

At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands ...

The awarded $1.7 million in funding will support the company’s preclinical and clinical progress on DMX-1001 (noribogaine), ...

The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing ...

The licensing of Talicia, an FDA-approved fixed-dose therapy, to key at-risk markets strategically combats an increasingly ...

In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

Siegfried Schmitt, PhD, vice-president, Technical at Parexel, answers questions on the use and benefits of real-world ...

Pharma news on AI's role in drug development, new FDA/EMA guidance, clinical advances, MFN pricing agreements, and ongoing quality control challenges.

Pharmaceutical Technology® spoke with Juliana Maynard, PhD, Head of Translational Imaging, at Medicines Discovery Catapult, ...

FDA emphasizes a shift from checkbox compliance to a holistic, quality systems-focused approach in pharmaceutical manufacturing. Post-warning letter meetings require demonstrated implementation of ...

Training in regulated industries must be job-specific and ongoing to meet GMP standards, moving beyond rote exercises to ensure personnel are "fit for purpose." Traditional training faces challenges ...

AI integration in pharma requires robust data governance, process harmonization, and human oversight to ensure quality assurance and regulatory compliance. AI applications in laboratories include ...